Search by Drug Name or NDC

    NDC 60760-0248-90 Glimepiride 4 mg/1 Details

    Glimepiride 4 mg/1

    Glimepiride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by St. Mary. The primary component is GLIMEPIRIDE.

    Product Information

    NDC 60760-0248
    Product ID 60760-248_f06e9242-c9fa-f3c9-e053-2a95a90a276a
    Associated GPIs 27200027000340
    GCN Sequence Number 025181
    GCN Sequence Number Description glimepiride TABLET 4 MG ORAL
    HIC3 C4K
    HIC3 Description ANTIHYPERGLYCEMIC, INSULIN-RELEASE STIMULANT TYPE
    GCN 05833
    HICL Sequence Number 010485
    HICL Sequence Number Description GLIMEPIRIDE
    Brand/Generic Generic
    Proprietary Name Glimepiride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Glimepiride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 4
    Active Ingredient Units mg/1
    Substance Name GLIMEPIRIDE
    Labeler Name St. Mary
    Pharmaceutical Class Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078181
    Listing Certified Through 2024-12-31

    Package

    NDC 60760-0248-90 (60760024890)

    NDC Package Code 60760-248-90
    Billing NDC 60760024890
    Package 90 TABLET in 1 BOTTLE, PLASTIC (60760-248-90)
    Marketing Start Date 2017-12-26
    NDC Exclude Flag N
    Pricing Information N/A